|
[1]Ravindranath MH, Muthugounder S, Presser N, et al. Anticancer therapeutic potential of soyisoflavone, genistein[J].Adv Exp Med Biol, 2004, 546∶121-165.
|
|
[2]Su SJ, Chow NH, Kung ML, et al.Effects of soy isoflavones on ap-optosis indutio G2/M arrest in human hepatoma cells involvementcaspase-3 activation, Bcl-2 and Bcl-XL downregulation andCdc2 kinase activity[J].J Nutr Cancer, 2003, 45 (1) ∶113-123.
|
|
[3]Blanc-Brude OP, Mesri M, Wall NR, et al.Therapeutic targetingof the survivin pathway in cancer:initiation of mitochondrial apopto-sis and suppression of tumor-associated angiogenesis[J].ClinCancer Res, 2003, 9∶2683-2692.
|
|
[4]Ikeguchi M, Ueda T, Sakatani T, et al.Expression of survivin mes-senger RNAcorrelates with poor prognosis in patients with hepatocel-lular carcinoma[J].Diagn Mol Pathol, 2002, 11 (1) ∶30-40.
|
|
[5]Chodon D, Banu SM, Padmavathi R, et al.Inhibition of cell prolif-eration and induction of apoptosis by genistein in experimental hepa-tocellular carcinoma[J].Mol Cell Biochem, 2006, 297 (1-2) ∶73-80.
|